Genetic landscape of resistance to CDK4/6 inhibition in circulating tumor DNA (ctDNA) analysis of the PALOMA3 trial of palbociclib and fulvestrant versus placebo and fulvestrant - Turner, N C; OʼLeary, B; Cutts, R (J Clin Oncol, 2018)
(Suppl.)